About Jonathan Taqqu
Form D filings for DaylightRx in 2024 list Jonathan Taqqu as president and director.
Jonathan Taqqu first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Taqqu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Taqqu works with at each company, as listed on that company's latest Form D.
DaylightRx, Inc. · Form D, Oct 30, 2024
JL
John Lee
Director